| Browse All

Whitehawk Therapeutics, Inc. (WHWK)

Healthcare | Biotechnology | Morristown, United States | NasdaqCM
4.11 USD -0.12 (-2.837%) ⇩ (April 17, 2026, 4 p.m. EDT)
After hours: 4.06 -0.05 (-0.052%) ⇩ (April 17, 2026, 7:41 p.m. EDT)

Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆
Hot Take | April 11, 2026, 4 p.m. EDT

Whitehawk Therapeutics, Inc. (WHWK) is a high-risk, low-reward investment with a significant negative profit margin and a high overall risk rating. The recent price action shows a range-bound pattern with a recent dip to $3.16, but it has since recovered slightly. The options activity suggests mixed sentiment, with puts indicating some bearish bias and calls showing potential bullish interest. However, the lack of clear directional signals and the company's weak financials make it a risky proposition for both short-term and long-term investors. With no dividend history and a low target mean price, it is not an attractive option for income-focused investors. Overall, this stock is not recommended for most investors due to its volatility and lack of fundamentals.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.093043
AutoARIMA0.145079
MSTL0.145621
AutoETS0.148246

Forecast horizon: 45 days | Selected: AutoTheta

Forecast Reliability
Score 45%
H-stat 8.04
Ljung-Box p 0.000
Jarque-Bera p 0.269
Excess Kurtosis -0.59
Attribute Value
Sector Healthcare
Revenue per Share 0.115
Market Cap 193,977,888
Forward P/E -3.43
Beta 0.62
Profit Margins -288.26%
Previous Name Aadi Bioscience, Inc.
Website https://ir.whitehawktx.com

As of April 11, 2026, 4 p.m. EDT: The options data shows mixed signals. For the April 17 expiration, there is significant put volume and open interest at the 2.5 strike, indicating potential bearish sentiment. However, there are also call options with high open interest at the 5.0 strike, suggesting some bullish speculation. The July 17 and October 16 expirations show minimal activity, with most options having zero volume or open interest. This lack of activity may indicate low confidence or limited market participation. The IV for calls is higher on the April 17 expiration, which could indicate increased volatility expectations, but the overall options activity does not provide a clear directional signal.


Info Dump

Attribute Value
52 Week Change 1.7290323
Address1 2 Headquarters Plaza
Address2 East Building 11th Floor
All Time High 78.0
All Time Low 1.21
Ask 5.17
Ask Size 2
Audit Risk 7
Average Analyst Rating 2.2 - Buy
Average Daily Volume10 Day 252,120
Average Daily Volume3 Month 170,280
Average Volume 170,280
Average Volume10Days 252,120
Beta 0.619
Bid 3.1
Bid Size 2
Board Risk 6
Book Value 2.891
City Morristown
Compensation As Of Epoch Date 1,735,603,200
Compensation Risk 9
Country United States
Crypto Tradeable 0
Currency USD
Current Price 4.11
Current Ratio 10.263
Custom Price Alert Confidence HIGH
Date Short Interest 1,774,915,200
Day High 4.3899
Day Low 4.0
Display Name Whitehawk Therapeutics
Earnings Call Timestamp End 1,742,387,400
Earnings Call Timestamp Start 1,742,387,400
Earnings Timestamp 1,773,318,600
Earnings Timestamp End 1,778,157,000
Earnings Timestamp Start 1,778,157,000
Ebitda -114,321,000
Ebitda Margins 0.0
Enterprise To Ebitda -0.422
Enterprise To Revenue 6.757
Enterprise Value 48,280,880
Eps Current Year -1.265
Eps Forward -1.2
Eps Trailing Twelve Months -0.32
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 3.4194
Fifty Day Average Change 0.69060016
Fifty Day Average Change Percent 0.2019653
Fifty Two Week Change Percent 172.90323
Fifty Two Week High 4.48
Fifty Two Week High Change -0.3699999
Fifty Two Week High Change Percent -0.08258926
Fifty Two Week Low 1.39
Fifty Two Week Low Change 2.7200003
Fifty Two Week Low Change Percent 1.9568348
Fifty Two Week Range 1.39 - 4.48
Financial Currency USD
First Trade Date Milliseconds 1,518,791,400,000
Float Shares 17,762,899
Forward Eps -1.2
Forward P E -3.425
Free Cashflow -53,653,000
Full Exchange Name NasdaqCM
Full Time Employees 23
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,775,001,600
Gross Margins 0.0
Gross Profits -84,578,000
Has Pre Post Market Data 1
Held Percent Insiders 0.14864999
Held Percent Institutions 0.75948995
Implied Shares Outstanding 47,196,564
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,630,022,400
Last Split Factor 1:15
Long Business Summary Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
Long Name Whitehawk Therapeutics, Inc.
Market us_market
Market Cap 193,977,888
Market State POSTPOST
Max Age 86,400
Message Board Id finmb_430225247
Most Recent Quarter 1,767,139,200
Name Change Date 2,026-04-16
Net Income To Common -20,596,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 199,169,500
Number Of Analyst Opinions 3
Open 4.31
Operating Cashflow -97,433,000
Operating Margins -16.0112
Overall Risk 8
Payout Ratio 0.0
Phone 551-321-2234
Post Market Change -0.052299976
Post Market Change Percent -1.2725055
Post Market Price 4.0577
Post Market Time 1,776,469,295
Prev Name Aadi Bioscience, Inc.
Previous Close 4.23
Price Eps Current Year -3.249012
Price Hint 4
Price To Book 1.4216534
Price To Sales Trailing12 Months 27.14876
Profit Margins -2.88258
Quick Ratio 10.035
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key buy
Recommendation Mean 2.2
Region US
Regular Market Change -0.12
Regular Market Change Percent -2.83688
Regular Market Day High 4.3899
Regular Market Day Low 4.0
Regular Market Day Range 4.0 - 4.3899
Regular Market Open 4.31
Regular Market Previous Close 4.23
Regular Market Price 4.11
Regular Market Time 1,776,456,000
Regular Market Volume 571,337
Return On Assets -0.64662004
Return On Equity -0.21819
Revenue Growth -1.0
Revenue Per Share 0.115
Sand P52 Week Change 0.36506534
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 8
Shares Outstanding 47,196,564
Shares Percent Shares Out 0.0147
Shares Short 693,909
Shares Short Previous Month Date 1,772,150,400
Shares Short Prior Month 780,896
Short Name Whitehawk Therapeutics, Inc.
Short Percent Of Float 0.0196
Short Ratio 3.3
Source Interval 15
State NJ
Symbol WHWK
Target High Price 7.0
Target Low Price 4.0
Target Mean Price 5.66667
Target Median Price 6.0
Total Cash 145,696,992
Total Cash Per Share 3.087
Total Debt 0
Total Revenue 7,145,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -0.32
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 2.477125
Two Hundred Day Average Change 1.6328752
Two Hundred Day Average Change Percent 0.6591816
Type Disp Equity
Volume 571,337
Website https://ir.whitehawktx.com
Zip 7,960